Company: PFSA
Filing Date: 2025-05-13
Form Type: S-4/A
Source: 0001213900-25-042224
Chunk: 6

Company: Profusa, Inc.
Filing Date: 2025-05-13
Form: S-4/A
Chunk 6
---
 its shares to Continental Stock Transfer & Trust Company, NorthView will redeem such public shares for a per -shareprice, payable in cash, equal to the pro rata portion of the trust account established at the consummation of NorthView’s initial public offering, calculated as of two business days prior to the consummation of the Business Combination. For illustrative purposes, based on 154,561shares subject to possible redemption, funds in the trust account of approximately $1.9million as of March21, 2025, this would have amounted to approximately $12.21 per issued and outstanding public share. If a public stockholder exercises its redemption rights in full, then it will be electing to exchange its public shares for cash and will no longer own public shares. See “Special Meeting of NorthView Holders — Redemption Rights”in the accompanying proxy statement/prospectus for a detailed description of the procedures to be followed if you wish to redeem your public shares for cash. Notwithstanding the foregoing, a public stockholder, together with any affiliate of such public stockholder or any other person with whom such public stockholder is acting in concert or as a “group” (as defined in Section 13(d)(3) of the U.S. Securities Exchange Act of 1934, as amended (“Exchange Act”)), will be restricted from redeeming its public shares with respect to more than an aggregate of 15% of the public shares. Accordingly, if a public stockholder, alone or acting in concert or as a group, seeks to redeem more than 15% of the public shares without the consent of NorthView, then any such shares in excess of that 15% limit would not be redeemed for cash. The consummation of the transactions contemplated by the Merger Agreement, including the occurrence of the Closing, is subject to the satisfaction or waiver of certain other closing conditions as described in the accompanying proxy statement/prospectus under the section entitled “Proposal 1 — The Business Combination Proposal — Merger Agreement — Conditions to Closing”. There can be no assurance that the parties to the Merger Agreement would waive any such provision of the Merger Agreement or that the transactions contemplated by the Merger Agreement, including the Closing, will be consummated. Material Financing Transactions: Since the completion of NorthView’s IPO in December 2021, NorthView has not completed any material financing transactions. However, as of the expected Closing Date of the Business Combination, the Sponsor will have lent to NorthView an estimated $